# Viridian Therapeutics (stock symbol: VRDN) Logo in transparent PNG and SVG formats

## Viridian Therapeutics Logo large

### Viridian Therapeutics Logo large Download PNG (26.49 KB)

![Viridian Therapeutics Logo large Download PNG (26.49 KB)](/img/orig/VRDN_BIG-f5d6e512.png)

### Viridian Therapeutics Logo large Download SVG (4.74 KB)

![Viridian Therapeutics Logo large Download SVG (4.74 KB)](/img/orig/VRDN_BIG-bcf58ebf.svg)

## Viridian Therapeutics Logo icon format

### Viridian Therapeutics Logo icon format Download PNG (56.16 KB)

![Viridian Therapeutics Logo icon format Download PNG (56.16 KB)](/img/orig/VRDN-0678eaf8.png)

### Viridian Therapeutics Logo icon format Download SVG (3.23 KB)

![Viridian Therapeutics Logo icon format Download SVG (3.23 KB)](/img/orig/VRDN-2d667bb7.svg)

## Viridian Therapeutics Logo large for dark backgrounds

### Viridian Therapeutics Logo large for dark backgrounds Download PNG (17.36 KB)

![Viridian Therapeutics Logo large for dark backgrounds Download PNG (17.36 KB)](/img/orig/VRDN_BIG.D-462e1d7b.png)

### Viridian Therapeutics Logo large for dark backgrounds Download SVG (4.62 KB)

![Viridian Therapeutics Logo large for dark backgrounds Download SVG (4.62 KB)](/img/orig/VRDN_BIG.D-9a3879fd.svg)

## Viridian Therapeutics Logo icon format for dark backgrounds

### Viridian Therapeutics Logo icon format for dark backgrounds Download PNG (33.52 KB)

![Viridian Therapeutics Logo icon format for dark backgrounds Download PNG (33.52 KB)](/img/orig/VRDN.D-51087b3d.png)

### Viridian Therapeutics Logo icon format for dark backgrounds Download SVG (3.14 KB)

![Viridian Therapeutics Logo icon format for dark backgrounds Download SVG (3.14 KB)](/img/orig/VRDN.D-5eb18d9c.svg)

## About Viridian Therapeutics

Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-003, a therapeutic antibody targeting IGF-1R for the treatment of TED. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021. Viridian Therapeutics, Inc. was founded in 2006 and is headquartered in Waltham, Massachusetts.

1. Website domain: viridiantherapeutics.com
2. Employees: 50
3. Marketcap: $1.20 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
